 |
| Electrocompetent Cells Market Growth |
The global Electrocompetent Cells Market is estimated to be valued at US$ 2.07 Bn in 2023 and is expected to
exhibit a CAGR of 10% over the
forecast period 2023 to 2030, as highlighted in a new report published by
Coherent Market Insights.
Market Overview:
Electrocompetent cells are chemically treated bacterial cells that can easily
uptake external DNA when exposed to an electric pulse or electric field. These
modified cells allow for efficient transformation of plasmid DNA, PCR products,
and ligation mixtures. They are widely utilized in various gene expression and
cloning applications due to their ability to rapidly introduce exogenous DNA.
Bacterial strains such as E.coli, S.cerevisiae and other yeast species are
commonly used to prepare electrocompetent cells. The increasing adoption of DNA
synthesis technology in drug discovery, molecular biology research and genetic
engineering is boosting the demand for electrocompetent cells.
Market key trends:
One of the key trends in the Electrocompetent
Cells Market Growth is the growing applications of gene and genome synthesis.
Gene synthesis allows researchers to design and build genes from scratch to
study their functions or produce desired gene products. It is widely adopted in
biotechnology, pharmaceutical and agriculture industries. This growing adoption
of gene synthesis technology is generating significant demand for
electrocompetent cells to rapidly transform synthesized DNA into bacterial
hosts for downstream applications. Furthermore, continuous technological
advancements to improve the efficiency and throughput of electrocompetent cells
preparation are also fueling the market growth. Advanced procedures allow
obtaining larger batches of highly competent cells in lesser time, thereby
supporting high volume gene expression and cloning experiments.
Porter’s Analysis
Threat of new entrants: The high costs associated with R&D, patents,
certifications, and manufacturing infrastructure makes it difficult for new
players to enter the market.
Bargaining power of buyers: The presence of numerous established players gives
buyers higher bargaining power. They can choose from a variety of product
options offered by different companies.
Bargaining power of suppliers: The key raw materials used in electrocompetent
cells such as calcium chloride and magnesium chloride are commodity chemicals
available from multiple suppliers globally. This eases supplier bargaining
power.
Threat of new substitutes: There exist no close substitutes for
electrocompetent cells currently as they are important tools for recombinant
DNA technology with no replacement.
Competitive rivalry: The electrocompetent cells market experiences strong
competition among leading established players.
Key Takeaways
The global Electrocompetent Cells market is expected to witness high growth,
exhibiting a CAGR of 10% over the
forecast period, due to increasing R&D investments in life sciences and
growing adoption of gene synthesis technology.
Regional analysis: North America dominates the global electrocompetent cells
market, owing to the presence of major market players and availability of
advanced research infrastructure. Asia Pacific is expected to grow at the
fastest pace during the forecast period due to increasing government funding
for synthetic biology and genomic research.
Key players operating in the electrocompetent cells market are Thermo Fisher
Scientific Inc., Merck KGaA, Agilent Technologies, Inc., QIAGEN N.V., Bio-Rad
Laboratories, Inc., New England Biolabs, Inc., GenScript Biotech Corporation,
Lucigen Corporation, Takara Bio Inc., Delphi Genetics S.A., IBA GmbH, Scarab
Genomics LLC, Zymo Research Corporation, Bioline GmbH (Meridian Bioscience),
Cell Applications, Inc.
Read More: https://www.ukwebwire.com/electrocompetent-cells-market-analysis/